Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Trisha Kers"'
Autor:
Ioannis Ntafoulis, Anne Kleijn, Cassandra Posthoorn-Verheul, Stijn L W Koolen, Trisha Kers, Chelsea W J den Hollander, Jie Ju, Yunlei Li, Andrew P Stubbs, Clemens M F Dirven, Sieger Leenstra, Martine L M Lamfers
Publikováno v:
Neuro-Oncology. 24:vii104-vii105
BACKGROUND Major obstacles that have impeded the development of effective new therapies for GBM include inter- and intratumoral heterogeneity, the blood-brain-barrier and use of sub-optimal cell line-based preclinical models. Taking these hurdles int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::762ff97f91b6b088e2ef7b1c631932dd
https://doi.org/10.1093/neuonc/noac209.392
https://doi.org/10.1093/neuonc/noac209.392
Autor:
Redeil N. Arreza, Alec Nowell A. Ranara, Trisha Kerstin C. Tan, Kathleen B. Aviso, Angelo Earvin Sy Choi
Publikováno v:
Cleaner Engineering and Technology, Vol 22, Iss , Pp 100817- (2024)
Significant volumes of wastewater, particularly from the textile industry, pose environmental concerns due to the presence of hazardous substances such as ortho-toluidine (OT). The photo-Fenton process can be used to break down and remove this hazard
Externí odkaz:
https://doaj.org/article/01e987271f7a4b85983281f9b1499ca3
Autor:
Ioannis Ntafoulis, Stijn L W Koolen, Chelsea W J den Hollander, Jie Ju, Trisha Kers, Thierry P P van den Bosch, Kranthi Panth, Laura Mezzanotte, Dana A M Mustafa, Andrew P Stubbs, Clemens M F Dirven, Sieger Leenstra, Martine L M Lamfers
Publikováno v:
Neuro-Oncology. 24:vii212-vii212
INTRODUCTION Little progress has been made in the development of effective new therapies for glioblastoma (GBM) the past decades. Fresh patient-derived GBM cell culture models have become the gold standard for GBM drug discovery and development. One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a47cf1ba6a4af519c81d84946f213bb
https://doi.org/10.1093/neuonc/noac209.814
https://doi.org/10.1093/neuonc/noac209.814
Autor:
Trisha Kers, Sieger Leenstra, Clemens M F Dirven, Stanley Van, Judith Van den Burg, Youri Hoogstrate, Pim J. French, Cassandra Verheul, Ioannis Ntafoulis, Martine L.M. Lamfers, Miao Chien, Cecile E.M.T. Beerens, Federica Fabro
Publikováno v:
Neuro-Oncology. 23:vi219-vi219
INTRODUCTION The search for effective therapies for gliomas is progressively moving towards patient-specific medicine. In order to test patient-tailored therapies, it is vital to develop protocols for reliable establishment of patient-derived glioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c70fcfeecf6de611f625ea822886cae7
https://doi.org/10.1093/neuonc/noab196.880
https://doi.org/10.1093/neuonc/noab196.880
Autor:
Tessa Pierson, Cassandra Verheul, Clemens M F Dirven, Martine L.M. Lamfers, Trisha Kers, Marielle van der Kaaij, Eduard A. Struys, Pim J. French, Sieger Leenstra, Gajja S. Salomons, Ya Gao
INTRODUCTION: In spite of significant attention IDH mutations have attracted in glioma research, in vitro model systems with endogenous IDH mutations remain scarce. Development of these models is crucial not only for unraveling the molecular mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3e58f4c5270166993a2f29efaa18f9
https://europepmc.org/articles/PMC6216648/
https://europepmc.org/articles/PMC6216648/
Autor:
Trisha Kers, M. Van Der Kaaij, Sieger Leenstra, J van Rij, Martine L.M. Lamfers, J.H.M. Prehn, Josie Hayes, Andreas Kremer, R Tching, Rutger K. Balvers, Clemens M F Dirven, Andreas U. Lindner, I Ntafoulis
Publikováno v:
Neuro Oncol
BACKGROUND The development of new therapeutic agents generally takes many years to translate to clinically-effective new treatments. Among the strategies to reduce this time frame, efforts are now being undertaken to investigate drug repurposing. Wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93a1e8074102e0e3d0e8a33ac66d2fe
https://doi.org/10.1093/neuonc/noz126.173
https://doi.org/10.1093/neuonc/noz126.173
Autor:
A.T. van der Ploeg, Youri Hoogstrate, Clemens M F Dirven, Martine L.M. Lamfers, Cassandra Verheul, M Aghababazadeh, E.A. Struys, M. C. Y. de Wit, Pim J. French, Trisha Kers, M. Van Der Kaaij, Sieger Leenstra
Publikováno v:
Neuro Oncol
BACKGROUND Despite considerable scientific efforts, endogenous in vitro isocitrate dehydrogenase (IDH)-mutated glioma models remain scarce. Availability of these models is key to understanding underlying molecular mechanisms and vital for the develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d24f64535e1277364990dc25191e2c
https://doi.org/10.1093/neuonc/noz126.193
https://doi.org/10.1093/neuonc/noz126.193
Autor:
Clemens M F Dirven, Tessa Pierson, Marielle van der Kaaij, Martine L.M. Lamfers, Eduard A. Struys, Sieger Leenstra, Pim J. French, Gajja S. Salomons, Ya Gao, Cassandra Verheul, Trisha Kers
Publikováno v:
Neuro-Oncology. 19:vi261-vi261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f4ffd23988002e85d9db9043346a277
https://doi.org/10.1093/neuonc/nox168.1072
https://doi.org/10.1093/neuonc/nox168.1072